MeSH term
Frequency | Condition_Probility | Adolescent | 25 | 0.0 |
Amino Acid Substitution | 7 | 0.0 |
Base Sequence | 19 | 0.0 |
Child | 45 | 0.0 |
Child, Preschool | 30 | 0.0 |
Connexins/*genetics | 123 | 71.0 |
DNA Primers | 10 | 0.0 |
Deafness/*genetics | 45 | 37.0 |
Hearing Loss, Sensorineural/genetics | 5 | 27.0 |
Humans | 158 | 0.0 |
*Mutation | 51 | 1.0 |
Polymerase Chain Reaction | 32 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 101 | 0.0 |
Sequence Deletion | 9 | 0.0 |
Adult | 33 | 0.0 |
Austria | 4 | 7.0 |
Gene Frequency | 22 | 0.0 |
Hearing Loss, Sensorineural/*genetics | 21 | 22.0 |
Mutation | 26 | 0.0 |
Point Mutation | 10 | 0.0 |
Sequence Analysis, DNA | 6 | 0.0 |
Chromosome Mapping | 13 | 0.0 |
Databases, Factual | 3 | 1.0 |
Deafness/genetics | 3 | 6.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 45 | 0.0 |
Female | 72 | 0.0 |
Infant | 12 | 0.0 |
Male | 66 | 0.0 |
Middle Aged | 14 | 0.0 |
DNA/analysis | 3 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Mutation, Missense/*genetics | 2 | 1.0 |
Pedigree | 42 | 0.0 |
Syndrome | 17 | 0.0 |
Founder Effect | 3 | 2.0 |
Genes, Recessive | 16 | 3.0 |
Heterozygote | 28 | 1.0 |
Gap Junctions | 3 | 37.0 |
Genes, Dominant | 4 | 0.0 |
Genotype | 29 | 0.0 |
Phenotype | 20 | 0.0 |
Skin Diseases/*genetics | 3 | 17.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Deafness/*diagnosis/*genetics | 7 | 87.0 |
*Membrane Transport Proteins | 2 | 0.0 |
Connexins/genetics | 8 | 17.0 |
Waardenburg's Syndrome/genetics | 3 | 14.0 |
DNA/chemistry/genetics | 10 | 1.0 |
DNA Mutational Analysis | 54 | 1.0 |
Family Health | 4 | 0.0 |
Hearing Loss, Sensorineural/*genetics/pathology | 2 | 20.0 |
Microsatellite Repeats | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 7 | 0.0 |
Animals | 14 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Mice | 7 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Alleles | 23 | 0.0 |
Case-Control Studies | 5 | 0.0 |
Chromosomes, Human, Pair 13/genetics | 2 | 3.0 |
Consanguinity | 5 | 1.0 |
DNA/genetics | 4 | 0.0 |
Deafness/*congenital/*genetics | 2 | 100.0 |
Haplotypes | 6 | 0.0 |
Homozygote | 13 | 0.0 |
Molecular Sequence Data | 24 | 0.0 |
Amino Acid Sequence | 16 | 0.0 |
Connexins/chemistry/*genetics | 7 | 58.0 |
Variation (Genetics)/*genetics | 3 | 1.0 |
Audiometry | 6 | 13.0 |
Follow-Up Studies | 3 | 0.0 |
Japan/epidemiology | 2 | 0.0 |
Prevalence | 13 | 0.0 |
Retrospective Studies | 3 | 0.0 |
Speech Perception | 2 | 28.0 |
Treatment Outcome | 2 | 0.0 |
*Genetic Screening | 4 | 2.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
*Gene Frequency | 2 | 0.0 |
Genetic Screening/methods | 5 | 4.0 |
Turkey | 3 | 2.0 |
Deafness/diagnosis/genetics | 2 | 100.0 |
English Abstract | 6 | 0.0 |
Gene Deletion | 5 | 0.0 |
Genetic Counseling | 6 | 3.0 |
Hearing Loss, Sensorineural/diagnosis/genetics | 2 | 100.0 |
Blotting, Southern | 3 | 0.0 |
Chromosomes, Human, Pair 13 | 5 | 3.0 |
*Sequence Deletion | 8 | 2.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
DNA, Mitochondrial/*genetics | 3 | 2.0 |
Hearing Loss, Sensorineural/epidemiology/*genetics | 3 | 75.0 |
DNA Primers/chemistry | 4 | 0.0 |
Mutation/*genetics | 19 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Deafness/*epidemiology/*genetics | 2 | 100.0 |
Point Mutation/*genetics | 4 | 1.0 |
Exons/genetics | 7 | 0.0 |
*Founder Effect | 5 | 4.0 |
Genes, Recessive/genetics | 5 | 6.0 |
Haplotypes/genetics | 2 | 0.0 |
Jews/*genetics | 4 | 2.0 |
Models, Genetic | 2 | 0.0 |
Polymorphism, Genetic/genetics | 3 | 0.0 |
Sequence Deletion/*genetics | 5 | 4.0 |
Aged | 6 | 0.0 |
Genetic Screening | 19 | 2.0 |
Hearing Loss/*genetics | 7 | 35.0 |
Deafness/epidemiology/*genetics | 5 | 83.0 |
Genes, Recessive/*genetics | 3 | 5.0 |
Age of Onset | 6 | 0.0 |
France/epidemiology | 2 | 1.0 |
Infant, Newborn | 10 | 0.0 |
Frameshift Mutation | 3 | 0.0 |
Mutation, Missense | 9 | 1.0 |
Prospective Studies | 5 | 0.0 |
*Gene Deletion | 4 | 0.0 |
*Genes, Recessive | 2 | 1.0 |
Genes, Dominant/genetics | 4 | 2.0 |
Mutation, Missense/genetics | 2 | 1.0 |
DNA Mutational Analysis/methods | 4 | 1.0 |
Genetic Screening/*methods | 4 | 2.0 |
Nucleic Acid Denaturation | 2 | 2.0 |
Sensitivity and Specificity | 5 | 0.0 |
Microsatellite Repeats/genetics | 3 | 0.0 |
Polymorphism, Single Nucleotide/genetics | 2 | 0.0 |
United States | 6 | 0.0 |
Nucleic Acid Hybridization/methods | 2 | 2.0 |
Deafness/diagnosis/*genetics | 2 | 25.0 |
Sequence Deletion/genetics | 5 | 2.0 |
*Alleles | 4 | 0.0 |
Europe | 4 | 1.0 |
Gap Junctions/genetics | 2 | 66.0 |
Reproducibility of Results | 5 | 0.0 |
Pregnancy | 3 | 0.0 |
*Prenatal Diagnosis | 2 | 0.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
Polymerase Chain Reaction/*methods | 4 | 0.0 |
Hearing Loss, Sensorineural/diagnosis/*genetics | 2 | 12.0 |
Variation (Genetics) | 4 | 0.0 |
*Cochlear Implantation | 2 | 50.0 |
Audiometry, Pure-Tone | 2 | 5.0 |
Severity of Illness Index | 4 | 0.0 |
Genetic Markers | 4 | 0.0 |
Israel | 4 | 2.0 |
Hearing Loss, Sensorineural/congenital/*genetics | 2 | 33.0 |
Gap Junctions/*genetics | 4 | 100.0 |
Deafness/*genetics/*physiopathology | 2 | 100.0 |
Gap Junctions/*physiology | 2 | 28.0 |
Linkage (Genetics) | 4 | 0.0 |
Auditory Threshold | 3 | 7.0 |
Deafness/*genetics/physiopathology | 3 | 33.0 |
Hearing Loss, Sensorineural/*genetics/physiopathology | 3 | 50.0 |
*Heterozygote | 4 | 1.0 |
Heteroduplex Analysis | 2 | 2.0 |
Keratoderma, Palmoplantar/*genetics | 5 | 35.0 |
*DNA Mutational Analysis | 2 | 1.0 |
Greece/epidemiology | 3 | 8.0 |
Hearing Loss, Sensorineural/ethnology/*genetics | 2 | 66.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Abnormalities, Multiple/genetics | 3 | 3.0 |
Deafness/classification/diagnosis/*genetics | 2 | 100.0 |
Hearing Impaired Persons/psychology/rehabilitation | 2 | 100.0 |
Hearing Loss, Bilateral/classification/diagnosis/*genetics | 2 | 100.0 |
Internet | 2 | 2.0 |
Norway | 2 | 1.0 |
Research | 2 | 3.0 |
*Genes, Dominant | 2 | 0.0 |
*Mutation, Missense | 7 | 1.0 |
Gap Junctions/physiology | 2 | 16.0 |
Amino Acid Substitution/genetics | 4 | 1.0 |
Aminoglycosides | 2 | 15.0 |
Genes, rRNA/genetics | 2 | 50.0 |
RNA, Ribosomal/*genetics | 2 | 20.0 |
Spain | 3 | 0.0 |
Genetic Diseases, Inborn/genetics | 2 | 4.0 |
Hearing Tests | 2 | 16.0 |
Connexins/*genetics/physiology | 2 | 66.0 |
Exons | 3 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Japan | 2 | 0.0 |
Italy | 4 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Connexins/*genetics/metabolism | 3 | 50.0 |
Heterozygote Detection | 5 | 0.0 |
Belgium | 2 | 3.0 |
*Frameshift Mutation | 2 | 1.0 |
*Chromosomes, Human, Pair 13 | 2 | 1.0 |
Hybrid Cells | 2 | 0.0 |
Chromosomes, Human, Pair 13/*genetics | 2 | 2.0 |
Jews/genetics | 2 | 2.0 |
Neonatal Screening/methods | 2 | 20.0 |
Disease Progression | 3 | 0.0 |
DNA, Mitochondrial/genetics | 2 | 4.0 |
Predictive Value of Tests | 2 | 0.0 |
Mutation/genetics | 2 | 0.0 |
China | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Finland | 2 | 0.0 |
Asian Continental Ancestry Group/*genetics | 3 | 0.0 |
Polymorphism, Single Nucleotide/*genetics | 3 | 1.0 |
Hearing Disorders/*genetics | 2 | 22.0 |
Heterozygote Detection/methods | 2 | 8.0 |
Incidence | 2 | 0.0 |
Audiology | 2 | 100.0 |
Hela Cells | 3 | 0.0 |
Transfection | 3 | 0.0 |
Hearing Loss, Sensorineural/*epidemiology/*genetics | 2 | 100.0 |
Population Surveillance | 2 | 1.0 |
